Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients”

3 trials

Showing 3 of 3 results

Not applicableUnknownNCT05181202
What this trial is testing

Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients

Who this might be right for
Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 20
Large-scale testing (Phase 3)Study completedNCT00992706
What this trial is testing

F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer

Who this might be right for
Breast CancerPalmar-plantar Erythrodysesthesia
Swiss Cancer Institute 91
Not applicableStudy completedNCT05755646
What this trial is testing

Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial

Who this might be right for
Hand-Foot SyndromeBreast Cancer
University Hospital Tuebingen 36

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation